Literature DB >> 21770924

Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations.

Mathieu Milh1, Nathalie Villeneuve, Mondher Chouchane, Anna Kaminska, Cécile Laroche, Marie Anne Barthez, Cyril Gitiaux, Céline Bartoli, Ana Borges-Correia, Pierre Cacciagli, Cécile Mignon-Ravix, Hélène Cuberos, Brigitte Chabrol, Laurent Villard.   

Abstract

PURPOSE: STXBP1 (MUNC18-1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy.
METHODS: STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video-electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video-EEG recordings. KEY
FINDINGS: We found five novel STXBP1 mutations in patients for whom video-EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression-burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression-burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow-up period. SIGNIFICANCE: We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in >10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21770924     DOI: 10.1111/j.1528-1167.2011.03181.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  42 in total

Review 1.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

2.  GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.

Authors:  Gemma L Carvill; Sarah Weckhuysen; Jacinta M McMahon; Corinna Hartmann; Rikke S Møller; Helle Hjalgrim; Joseph Cook; Eileen Geraghty; Brian J O'Roak; Steve Petrou; Alison Clarke; Deepak Gill; Lynette G Sadleir; Hiltrud Muhle; Sarah von Spiczak; Marina Nikanorova; Bree L Hodgson; Elena V Gazina; Arvid Suls; Jay Shendure; Leanne M Dibbens; Peter De Jonghe; Ingo Helbig; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurology       Date:  2014-03-12       Impact factor: 9.910

Review 3.  Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms.

Authors:  Anand K Srivastava; Charles E Schwartz
Journal:  Neurosci Biobehav Rev       Date:  2014-04-04       Impact factor: 8.989

Review 4.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

5.  Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression.

Authors:  Heather E Olson; McKenna Kelly; Christopher M LaCoursiere; Rebecca Pinsky; Dimira Tambunan; Catherine Shain; Sriram Ramgopal; Masanori Takeoka; Mark H Libenson; Kristina Julich; Tobias Loddenkemper; Eric D Marsh; Devorah Segal; Susan Koh; Michael S Salman; Alex R Paciorkowski; Edward Yang; Ann M Bergin; Beth Rosen Sheidley; Annapurna Poduri
Journal:  Ann Neurol       Date:  2017-02-14       Impact factor: 10.422

6.  Epilepsy. Genetics of early-onset epilepsy with encephalopathy.

Authors:  Rima Nabbout; Olivier Dulac
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

Review 7.  Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.

Authors:  Markus von Deimling; Ingo Helbig; Eric D Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

8.  Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome.

Authors:  Albert Orock; Sreemathi Logan; Ferenc Deak
Journal:  Mol Cell Neurosci       Date:  2017-12-05       Impact factor: 4.314

9.  Analysis of conditional heterozygous STXBP1 mutations in human neurons.

Authors:  Christopher Patzke; Yan Han; Jason Covy; Fei Yi; Stephan Maxeiner; Marius Wernig; Thomas C Südhof
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

10.  Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life.

Authors:  Julien Thevenon; Mathieu Milh; François Feillet; Judith St-Onge; Yannis Duffourd; Clara Jugé; Agathe Roubertie; Delphine Héron; Cyril Mignot; Emmanuel Raffo; Bertrand Isidor; Sandra Wahlen; Damien Sanlaville; Nathalie Villeneuve; Véronique Darmency-Stamboul; Annick Toutain; Mathilde Lefebvre; Mondher Chouchane; Frédéric Huet; Arnaud Lafon; Anne de Saint Martin; Gaetan Lesca; Salima El Chehadeh; Christel Thauvin-Robinet; Alice Masurel-Paulet; Sylvie Odent; Laurent Villard; Christophe Philippe; Laurence Faivre; Jean-Baptiste Rivière
Journal:  Am J Hum Genet       Date:  2014-07-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.